SEC Form 4 · accession 0001179110-15-004877
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin Oconnor
Director
Period of report
Mar 12, 2015
Accepted (ET)
Mar 13, 2015 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 12, 2015 | M | 5,000 | $11.85 | A | 47,849 | D | |
| Common Stock | Mar 12, 2015 | S | 5,000 | $18.22 | D | 42,849 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $11.85 | Mar 12, 2015 | M | 5,000 | A | — | May 18, 2015 | Common Stock | 5,000 | 0 | D |
Explanation of responses
- F1Option grant was fully exercisable on May 19, 2008.